LAWSUITS NEWS & LEGAL INFORMATION
Avandia Lawyer Interviews
January 15, 2011. By Heidi Turner.
Read [ Attorney: Don't Wait to File Avandia Claim ]
Miami, FL If you suffered Avandia side effects and have not yet filed a claim against GlaxoSmithKline, time could be running out. That's the word from J. Benton Stewart II, attorney at Stewart Law, P.L.L.C. Although Avandia settlements have been announced, there is no guarantee that further settlement funding will be issued, meaning patients who suffered an Avandia heart attack or other serious Avandia side effects should speak with an attorney about their claim.
August 12, 2009. By Heidi Turner.
Read [ Attorney says Clock's Ticking on Filing Avandia Lawsuits ]
Minneapolis, MN If you believe you may have been harmed by the use of Avandia, it is important to note that your time to file a lawsuit against the maker of the drug could be running out. According to Stuart Goldenberg, senior partner at Goldenberg & Johnson, the statute of limitations in many states is coming up soon, and there still may be people who do not realize that the injury they have suffered could be related to their Avandia use.
July 22, 2009. By Heidi Turner.
Read [ Attorney Says Time's Running Out for Filing Avandia Lawsuits ]
St. Louis, MO If you are a patient taking Avandia and have suffered a heart attack or stroke, your time for filing a lawsuit may be running out, according to attorney Jeff Lowe, with The Lowe Law Firm. Avandia is used to treat type 2 diabetes mellitus but studies have linked Avandia to an increased risk of adverse heart events.
July 27, 2008. By Brenda Craig.
Read [ Roger Drake: Attorney Believes More Avandia Cases To Come ]
Los Angeles, CA The legal team at Baum, Hedlund, Aristei & Goldman in Los Angeles is among the most successful drug liability litigators in the country. It has fought and won hundreds of personal injury and wrongful death cases against pharmaceutical giant GlaxoSmithKline (GSK) related to the antidepressant Paxil. Now attorney Roger Drake at the firm is representing a large number of people in another suit against GSK, this time related to the drug Avandia.